Abamectin
ADI: 0-2 µg/kg body weight (1997)
Established for the sum of abamectin and (Z)-8,9 isomer by the 1997 JMPR.
Residue Definition: Avermectin B1a
Species |
Tissue |
MRL (µg/kg) |
Step |
JECFA |
CCRVDF |
Cattle |
Liver |
100 |
7 |
47 |
10V, 11IV |
Cattle |
Kidney |
50 |
7 |
47 |
10V, 11IV |
Cattle |
Fat |
100 |
7 |
47 |
10V, 11IV |
ADI: 0-0.1 µg/kg body weight (1994)
ADI based on the acute pharmacological effects of carazolol.
Residue Definition: Carazolol
Species |
Tissue |
MRL (µg/kg) |
Step |
JECFA |
CCRVDF |
|
Pig |
Muscle |
5 |
1/ |
7 |
38, 43, 52 |
7V,8V,9IV,10II,11IV |
Pig |
Liver |
25 |
|
7 |
38, 43, 52 |
7V,8V,9IV,10II,11IV |
Pig |
Kidney |
25 |
|
7 |
38, 43, 52 |
7V,8V,9IV,10II,11IV |
Pig |
Fat/Skin |
5 |
1/ |
7 |
38, 43, 52 |
7V,8V,9IV,10II,11IV |
1/ The concentration at the injection site two hours after treatment may result in an intake that exceeds the acute RfD. Therefore, unless appropriate measures can be taken to ensure that residues at the injection site do not exceed the acute RfD, the uses of carazolol during the transport of animals to slaughter is inconsistent with safe use of the drug (52nd JECFA).Chlortetracycline/Oxytetracycline/Tetracycline
ADI: 0-30 µg/kg body weight (1998)
Group ADI for chlortetracycline, oxytetracycline and tetracycline.
Residue Definition: Parent drugs, singly or in combination.
Species |
Tissue |
MRL (µg/kg) |
Step |
JECFA |
CCRVDF |
|
Cattle |
Muscle |
200 |
|
7 |
45, 47, 50 |
9V, 10V, 11IV |
Pig |
Muscle |
200 |
|
7 |
45, 47, 50 |
9V, 10V, 11IV |
Sheep |
Muscle |
200 |
|
7 |
45, 47, 50 |
9V, 10V, 11IV |
Poultry |
Muscle |
200 |
|
7 |
45, 47, 50 |
9V, 10V, 11IV |
Fish |
Muscle |
200 |
T 1/ |
7 |
50 |
11V |
Giant prawn |
Muscle |
200 |
1/2/ |
7 |
50 |
11V |
Cattle |
Liver |
600 |
|
7 |
45, 47, 50 |
9V, 10V, 11IV |
Pig |
Liver |
600 |
|
7 |
45, 47, 50 |
9V, 10V, 11IV |
Sheep |
Liver |
600 |
|
7 |
45, 47, 50 |
9V, 10V, 11IV |
Poultry |
Liver |
600 |
|
7 |
45, 47, 50 |
9V, 10V, 11IV |
Cattle |
Kidney |
1200 |
|
7 |
45, 47, 50 |
9V, 10V, 11IV |
Pig |
Kidney |
1200 |
|
7 |
45, 47, 50 |
9V, 10V, 11IV |
Sheep |
Kidney |
1200 |
|
7 |
45, 47, 50 |
9V, 10V, 11IV |
Poultry |
Kidney |
1200 |
|
7 |
45, 47, 50 |
9V, 10V, 11IV |
Cattle |
Milk |
100 |
|
7 |
45, 47 |
9V, 10V, 11IV |
Sheep |
Milk |
100 |
|
7 |
45, 47 |
9V, 10V, 11IV |
Poultry |
Eggs |
400 |
|
7 |
45, 47, 50 |
9V, 10V, 11IV |
See also oxytetracycline.Cyfluthrin
1/ Applies only to oxytetracycline.
2/ Penaeus monodon. The current Codex MRL at 100 µg/kg in giant prawn for oxytetracycline adopted in 1997.
ADI: 0-20 µg/kg body weight (1997)
Residue Definition: Cyfluthrin
Species |
Tissue |
MRL (µg/kg) |
Step |
JECFA |
CCRVDF |
Cattle |
Muscle |
20 |
7 |
48 |
11V |
Cattle |
Liver |
20 |
7 |
48 |
11V |
Cattle |
Kidney |
20 |
7 |
48 |
11V |
Cattle |
Fat |
200 |
7 |
48 |
11V |
Cattle |
Milk |
40 |
7 |
48 |
11V |
ADI: 0-10 µg/kg body weight (1998)
Residue Definition: Eprinomectin B1a
Species |
Tissue |
MRL (µg/kg) |
Step |
JECFA |
CCRVDF |
Cattle |
Muscle |
100 |
7 |
50 |
11V |
Cattle |
Liver |
2000 |
7 |
50 |
11V |
Cattle |
Kidney |
300 |
7 |
50 |
11V |
Cattle |
Fat |
250 |
7 |
50 |
11V |
Cattle |
Milk |
20 |
7 |
50 |
11V |
ADI: 0-30 µg/kg body weight (1997)
Residue Definition: Flumequine
Species |
Tissue |
MRL (µg/kg) |
Step |
JECFA |
CCRVDF |
|
Cattle |
Muscle |
500 |
|
7 |
42, 48, 54 |
11V |
Pig |
Muscle |
500 |
|
7 |
42, 48, 54 |
11V |
Sheep |
Muscle |
500 |
|
7 |
42, 48, 54 |
11V |
Chicken |
Muscle |
500 |
|
7 |
42, 48, 54 |
11V |
Trout |
Muscle |
500 |
1/ |
7 |
42, 48, 54 |
11V |
Cattle |
Liver |
500 |
|
7 |
42, 48, 54 |
11V |
Pig |
Liver |
500 |
|
7 |
42, 48, 54 |
11V |
Sheep |
Liver |
500 |
|
7 |
42, 48, 54 |
11V |
Chicken |
Liver |
500 |
|
7 |
42, 48, 54 |
11V |
Cattle |
Kidney |
3000 |
|
7 |
42, 48, 54 |
11V |
Pig |
Kidney |
3000 |
|
7 |
42, 48, 54 |
11V |
Sheep |
Kidney |
3000 |
|
7 |
42, 48, 54 |
11V |
Chicken |
Kidney |
3000 |
|
7 |
48, 54 |
11V |
Cattle |
Fat |
1000 |
|
7 |
48, 54 |
11V |
Pig |
Fat |
1000 |
|
7 |
48, 54 |
11V |
Sheep |
Fat |
1000 |
|
7 |
48, 54 |
11V |
Chicken |
Fat |
1000 |
|
7 |
48, 54 |
11V |
1/ Muscle/skin in normal proportion.